Home
Notification
Profile
Trending Articles
News
Bookmarked and Liked
Creator Center
Settings
qwen ers
--
Follow
Injective Labs CEO ericinjective gave a talk
#nyuniversity
today on the rising institutional adoption of CRYPTO.
Joining him were leaders from
#BlackRock
,
#jpmorgan
and FTI_US
#INJ
#INJECTIVE
Disclaimer: Includes third-party opinions. No financial advice. May include sponsored content.
See T&Cs.
37
0
Replies
0
Explore the latest crypto news
⚡️ Be a part of the latests discussions in crypto
💬 Interact with your favorite creators
👍 Enjoy content that interests you
Email / Phone number
Sign Up
Login
Relevant Creator
qwen ers
@Square-Creator-504642421
Follow
Explore More From Creator
Injective has always been early. Early to 🥷 DeFi in 2020 🥷 Zero gas fees in 2021 🥷 Sector specific chains in 2022 🥷 RWAs in 2023 🥷 AI in 2024 🥷 [Redacted] in 2025
--
100 Million Blocks officially processed #Injective currently has one of the fastest block times in all of crypto
--
Meme Bridge Spotted Only possible on Injective #INJECTIVE #Solana
--
Injective has AI, memes and RWAs. Everything finance on one lightning fast L1.
--
New vault is now live on Mito: $AGENT-INJ! The first AI token on Injective generated entirely via the latest release of iAgent: the first on-chain AI agent creator
--
Latest News
Ross Ulbricht's Pardon Probability Rises to 84% on Kalshi
--
Eric Trump Hints at Upcoming Developments in Ethereum Holdings
--
Trump's Inauguration Ceremony and Executive Orders
--
Trump's Inauguration Set Under Chief Justice Roberts
--
TikTok Resumes Services After Agreement With Internet Providers
--
View More
Trending Articles
$PEPE 🔍 Detailed Analysis for $PEPE (Exchange: Binance, Cre
joma al abi
Just imagine the fear now in the market tomorrow what big co
M S
$XRP SHORT LIQUIDATION ANALYSIS Short Liquidation Trigger:
FRED CHARLES
$DOGE Dogecoin's (DOGE) current price is around $0.359341, w
GM crypto single
🔥 #SHIBA 🚀 The $1 Dream: Is It Possible? 🔥 What if SHIB
Trader HuSsain
View More
Sitemap
Cookie Preferences
Platform T&Cs